A recent discussion on X pointed out an uncomfortable pattern: the diagnostic thresholds for common conditions keep shifting, instantly turning large numbers of previously healthy people into patients—and reliable customers for the pharmaceutical industry. Hypertension, prediabetes, and diabetes were the examples cited. Those cases are well documented. They are also part of a larger process that has increasingly treated normal aging itself as a collection of medical deficienc

In a significant move aimed at tackling high prescription drug costs, President Donald Trump has launched TrumpRx.gov, a federal government-backed website that provides Americans with access to dramatically reduced prices on dozens of commonly prescribed medications. The initiative, which builds on the administration's Most-Favored-Nation pricing approach, promises savings

As Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. continues his vocal campaign against direct-to-consumer (DTC) pharmaceutical advertising, the push to ban drug ads on television remains a contentious battleground in U.S. health policy. Kennedy, a longtime critic of the pharmaceutical industry, has made restricting these ads a cornerstone of his agenda under the Trump administration.